Mycobacterium kansasii infections in patients with cancer

被引：22

作者：

Jacobson, KL

Teira, R

Libshitz, HI

Raad, I

Rolston, KVI

Tarrand, J

Whimbey, E

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Infect Dis Sect, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA

[3] Univ Texas, MD Anderson Canc Ctr, Microbiol Sect, Houston, TX 77030 USA

[4] Hosp Basurto, Infect Dis Sect, Bilbao, Spain

来源：

CLINICAL INFECTIOUS DISEASES | 2000年 / 30卷 / 06期

关键词：

D O I：

10.1086/313801

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mycobacterium kansasii was isolated from 25 patients with cancer who were cared for at the University of Texas M. D. Anderson Cancer Center (Houston) from January 1987 through December 1996, Two patients (8%) had disseminated disease, and 23 (92%) had pleuropulmonary isolates only. Signs and symptoms of mycobacterial infection at the time of diagnosis were often minimal or absent despite substantial radiographically evident involvement. The infections responded well to rifampin-based anti-mycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer.

引用

页码：965 / 969

页数：5

共 8 条

[1]

AHN CH, 1982, AM REV RESPIR DIS, V125, P388

[2]

Kent P. T., 1985, PUBLIC HLTH MYCOBACT

[3]

LILLO M, 1990, REV INFECT DIS, V12, P760

[4] MYCOBACTERIUM-KANSASII INFECTIONS IN WESTERN-AUSTRALIA (1962-1987) [J].